Title:
肝細胞がん（ＨＣＣ）およびその他のがんに対する免疫療法で使用するための新規ペプチドおよびペプチド組み合わせ
Document Type and Number:
Japanese Patent JP7026411
Kind Code:
B2
Abstract:
A method of eliciting an immune response in a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of IYVTSIEQI (SEQ ID NO: 214), in which the peptide is in a complex with an MHC molecule.
Inventors:
Weinschenk, Toni
Andrea, Mare
Fritche, jens
Muller, Philip
Vibe, Anita
Kutcher, sara
Andrea, Mare
Fritche, jens
Muller, Philip
Vibe, Anita
Kutcher, sara
Application Number:
JP2020106475A
Publication Date:
February 28, 2022
Filing Date:
June 19, 2020
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C07K7/06; A61K35/15; A61K35/17; A61K38/08; A61K39/395; A61P35/00; C07K14/725; C07K19/00; C12N5/0783; C12N5/10; C12N15/12; C12N15/62; C12N15/63; C12P21/02
Domestic Patent References:
| JP2012504393A |
Foreign References:
| WO2014039675A1 | ||||
| WO2004018667A1 |
Attorney, Agent or Firm:
Takashi Shoji